ASIC1a activation by amitriptyline and FMRF-amide is removed by serine proteases.
Analgesia induced by certain tricyclic antidepressants has been largely used for decades, yet the mechanisms involved are incompletely understood. Starting from previously reported dual effects of amitriptyline on wild-type ENaC (Pena F, et al. J Pharm Pharmacol 54:1393-8: 2002), we extended our study to ASIC1a by performing a series of whole cell and single-channel recordings of proton-activated currents in HEK293 cells. Acid pulses were applied at 2 or 5 min intervals, and amitriptyline (1-500 microM) was applied at a holding pH of 7.4 or 8.4 between pulses. Dose-response plots were fitted with dual Hill type functions, yielding a half-activatory constant of 0.3 microM and a half-inhibitory constant of 382 microM at pH 7.4. At pH 8.4 both constants were shifted to higher values (0.5 and 444 microM, respectively). In whole-cell experiments, FMRF-amide increased the peak amplitude of ASIC1a transients at 0.1 microM and decreased it at 1 and 100 microM. Single-channel recordings were idealized and fitted using an 8-state linear connectivity model comprising four consecutive activation steps. Both amitriptyline (1 microM) and FMRF-amide (0.1 microM) increased the unitary current amplitude, and modified the opening and closing rates of the first gating mode. They also increased the transition rate from the second to the first gating mode, and the rate of final closure. The activatory effect of both compounds vanished after a mild trypsin pretreatment, suggesting the existence of activatory sites for FMRF-amide and amitriptyline in the outer vestibule of ASIC1a, which can be removed by exo- or endogenous serine-proteases.
Marin
Adela N
AN
Department of Biophysics and Physiology, Faculty of Biology, University of Bucharest, Bucharest, Romania.
Prica
Corina M
CM
Amuzescu
Bogdan P
BP
Neaga
Emil I
EI
Flonta
Maria-Luiza G
ML
D062565:Acid Sensing Ion Channels; D000639:Amitriptyline / Q000494:pharmacology*; D000698:Analgesia; D002460:Cell Line; D004594:Electrophysiology; D019835:FMRFamide / Q000494:pharmacology*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D049990:Membrane Transport Modulators; D009419:Nerve Tissue Proteins / Q000819:agonists* / Q000378:metabolism; D012697:Serine Endopeptidases / Q000494:pharmacology*; D062687:Sodium Channel Agonists; D015222:Sodium Channels / Q000378:metabolism
C568266:ASIC1 protein, human; D062565:Acid Sensing Ion Channels; D049990:Membrane Transport Modulators; D009419:Nerve Tissue Proteins; D062687:Sodium Channel Agonists; D015222:Sodium Channels; D000639:Amitriptyline; D019835:FMRFamide; D012697:Serine Endopeptidases